A New Multi-Factor Risk Score System Depending on Gene Mutation and Overexpression for Predicting the Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

被引：0
|
作者：
Yu, Guo-Pan
Yin, Changxin
Wu, Fuqun
Xu, Dan
Zheng, Zhongxin
Jiang, Ling
Chen, Fang
Jiang, Xuejie
Liu, Qifa
Meng, Fanyi
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5088
引用
收藏
页数：2
相关论文
共 26 条
  • [1] Gene mutation profile and risk stratification in AML1-ETO-positive acute myeloid leukemia based on next-generation sequencing
    Yu, Guopan
    Yin, Changxin
    Wu, Fuqun
    Jiang, Ling
    Zheng, Zhongxin
    Xu, Dan
    Zhou, Jiaheng
    Jiang, Xuejie
    Liu, Qifa
    Meng, Fanyi
    ONCOLOGY REPORTS, 2019, 42 (06) : 2333 - 2344
  • [2] Gene Mutation Profile and Risk Stratification in AML1-ETO-Positive Acute Myeloid Leukemia Based on Next-Generation Sequencing
    Yu, Guopan
    Yin, Changxin
    Wu, Fuqun
    Jiang, Ling
    Zheng, Zhongxin
    Xu, Dan
    Zhou, Jiaheng
    Jiang, Xuejie
    Liu, Qifa
    Meng, Fanyi
    BLOOD, 2018, 132
  • [3] A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within AML1-ETO-Positive Acute Myeloid Leukemia
    Yang, Min
    Zhang, Yi
    Wang, Jinghan
    Liu, Lixia
    Wang, Chengcheng
    Lou, Feng
    Cao, Shanbo
    Jin, Jie
    BLOOD, 2020, 136
  • [4] APP Gene Is Correlated with C-KIT Mutations and Indicates Poor Disease Outcome in AML1-ETO-Positive Acute Myeloid Leukemia
    Yu, Guopan
    Jiang, Ling
    Meng, Fan Yi
    Yin, Changxin
    Wang, Zhixiang
    Zhou, Hongsheng
    Jiang, Xuejie
    Zhong, Qingxiu
    Cao, Rui
    Liao, Libin
    BLOOD, 2014, 124 (21)
  • [5] Effects of the DNA methylase inhibitor zebularine on global gene expression in AML1-ETO-positive acute myeloid leukemia.
    Flotho, C
    Song, GC
    Downing, JR
    BLOOD, 2005, 106 (11) : 840A - 840A
  • [6] Amyloid precursor protein has clinical and prognostic significance in AML1-ETO-positive acute myeloid leukemia
    Yu, Guopan
    Yin, Changxin
    Jiang, Ling
    Xu, Dan
    Zheng, Zhongxin
    Wang, Zhixiang
    Wang, Chunli
    Zhou, Hongsheng
    Jiang, Xuejie
    Liu, Qifa
    Meng, Fanyi
    ONCOLOGY LETTERS, 2018, 15 (01) : 917 - 925
  • [7] Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML
    Xu, Dan
    Yang, Ying
    Yin, Zhao
    Tu, Sanfang
    Nie, Danian
    Sun, Qixin
    Huang, Zhengqian
    Zhang, Yu
    Yu, Guopan
    BLOOD, 2022, 140 : 9097 - 9097
  • [8] Clinical outcome of children and adolescents with AML1/ETO and PML/RAR alpha fusion gene positive acute myeloid leukemia
    Sárper, N
    Özbek, U
    Agaoglu, L
    Anak, S
    Devecioglu, Ö
    Özgen, Ü
    Yalman, N
    Eryilmaz, E
    Gedikoglu, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 99 - 99
  • [9] Frequency and clinical features of ASXL2 gene mutation in acute myeloid leukemia patients with AML1-ETO fusion gene positive
    赵俊霞
    ChinaMedicalAbstracts(InternalMedicine), 2016, 33 (04) : 231 - 232
  • [10] Uncovering the oncogenic role of TET1 and 5-hydroxymethylcytosine (5hmC) marks in AML1-ETO-positive acute myeloid leukemia
    He, J.
    Bamezai, S.
    Sahin, D.
    Mohr, F.
    Ciccarone, F.
    Vegi, N. M.
    Pulikkottil-Jose, A.
    Mulaw, M. A.
    Caiafa, P.
    Doehner, K.
    Doehner, H.
    Feuring-Buske, M.
    Buske, C.
    Rawat, V. P. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 10 - 10
123